Selective elimination of erosive cells
The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
11.07.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
|---|---|
| AbstractList | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
| Author | Soederstroem, Kalle Galsgaard, Elisabeth Douglas |
| Author_xml | – fullname: Soederstroem, Kalle – fullname: Galsgaard, Elisabeth Douglas |
| BookMark | eNrjYmDJy89L5WRQC07NSU0uySxLVUjNyczNzEssyczPU8hPU0gtyi8GCSen5uQU8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-NBgQ0MzS3MzC3MnI2Ni1AAAbwQpuw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US11697687B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US11697687B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:06:13 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US11697687B23 |
| Notes | Application Number: US201916718935 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230711&DB=EPODOC&CC=US&NR=11697687B2 |
| ParticipantIDs | epo_espacenet_US11697687B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20230711 |
| PublicationDateYYYYMMDD | 2023-07-11 |
| PublicationDate_xml | – month: 07 year: 2023 text: 20230711 day: 11 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | NOVO NORDISK A/S |
| RelatedCompanies_xml | – name: NOVO NORDISK A/S |
| Score | 3.4804335 |
| Snippet | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Selective elimination of erosive cells |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230711&DB=EPODOC&locale=&CC=US&NR=11697687B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFfVNq6L1IILkLZiY-yEIuShCD0wjfSvZ6S5UpC0m4t93dkmtL_q2zMIeA998M7PHANwvAvRCXAhDCKQAxXcrI2DMNByHM-S2ibaQJ7rDkTconeeZO-vA2_YtjPon9Et9jkiIQsJ7o-z1ZpfEStXdyvqBLUm0fsqnUaq30bG81UzYTeMom4zTcaInSVQW-uglsiyPiDfwYzLXe-RG-xIN2WssX6VsflNKfgz7Expt1ZxAh696cJhsK6_14GDYHnhTs8VefQp6oUrWkHXS-LuqxSWXqa2FxonppFgm4eszuMuzaTIwaML5z-7mZbFbm30OXYr6-QVoXiAcm-jbdSvbQVOEQYXVo4s-IpKTEl5C_-9x-v91XsGR1JRMUFrWNXSbj09-Q8zasFulkm-_EX3N |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2LrK4LkFmzM-xCEvIjapMUk0ltJtrugSFtMxL_v7JJaL3pbZmF3duCbb2f2MQA3C5uYDlkwhTGCAYpllIpdVSNF12lFqDYiGuMnuklqxoX-ODNmHXjbvIUR_4R-ic8REVEE8d4If73eJrECcbeyvq1eUbS6j3I3kNvomN9qRuwGnhtOJ8HEl33fLTI5fXZV1UTitS0P3fUOb3A0hC8ef5Wy_k0p0QHsTnG0ZXMIHbrsQ8_fVF7rw17SHnhjs8VefQRyJkrWoHeS6LuoxcXVlFZMosh0XMyT8PUxXEdh7scKTjj_Wd28yLa6aSfQxaifnoJk2kzXkL4No9R0MmKOXZLyziAWIQQ3Kc4Ahn-PM_yv8wp6cZ6M5-OH9OkM9rnVeLJSVc-h23x80gtk2aa6FOb5BtBAgMA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Selective+elimination+of+erosive+cells&rft.inventor=Soederstroem%2C+Kalle&rft.inventor=Galsgaard%2C+Elisabeth+Douglas&rft.date=2023-07-11&rft.externalDBID=B2&rft.externalDocID=US11697687B2 |